Início › Doenças Autoimunes › Carolina do Norte › Durham
Ensaios clínicos de Doenças Autoimunes em Durham, NC
15 estudos para Doenças Autoimunes estão buscando participantes em locais em Durham e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Environmental Risk Factors for the Anti-synthetase Syndrome
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · a 7 mi de distância
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecrutandoFase 3
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecrutandoFase 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · a 10 mi de distância
Daratumumab in Primary Antiphospholipid Syndrome
RecrutandoFase 1/2
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecrutandoFase 1
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecrutandoFase 3
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecrutandoFase 3
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecrutandoFase 1/2
- UNC Chapel Hill, Chapel Hill · a 10 mi de distância
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecrutandoFase 2/3
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RecrutandoFase 3
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecrutandoFase 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · a 10 mi de distância
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecrutandoFase 1
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi de distância
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecrutandoFase 1
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Duke University, Durham
Ensaios de Doenças Autoimunes em outras cidades
- Houston, TX21 estudos
- Washington, DC19 estudos
- New York City, NY19 estudos
- Philadelphia, PA16 estudos
- Boston, MA13 estudos
- Los Angeles, CA12 estudos
- Chicago, IL12 estudos
- Dallas, TX9 estudos
- Cleveland, OH8 estudos
- Atlanta, GA8 estudos
- Milwaukee, WI8 estudos
- Portland, OR8 estudos
Outros estudos em Durham
- Câncer de Mama63 estudos
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células39 estudos
- Mieloma Múltiplo37 estudos
- Câncer Metastático33 estudos
- Leucemia Mieloide Aguda33 estudos
- Câncer de Pulmão32 estudos
- Câncer de Próstata32 estudos
- Câncer Colorretal28 estudos
- Leucemia Linfocítica Crônica27 estudos
- Câncer de Ovário27 estudos
- Insuficiência Cardíaca26 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.